Published in Am Rev Respir Dis on October 01, 1970
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother (1982) 3.82
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother (1997) 3.05
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol (1985) 2.68
Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis. Antimicrob Agents Chemother (1986) 2.48
Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol (2002) 2.12
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother (1982) 1.89
Quality control of individual components used in Middlebrook 7H10 medium for mycobacterial susceptibility testing. J Clin Microbiol (1988) 1.32
Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare. Antimicrob Agents Chemother (1981) 1.05
Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 3.15
An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results. Am Rev Respir Dis (1983) 1.90
Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke (2000) 1.77
Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections. Am Rev Respir Dis (1987) 1.62
Release of superoxide anion from resident and activated mouse peritoneal macrophages infected with Mycobacterium intracellulare. Am Rev Respir Dis (1984) 1.55
Rapid assessment of mycobacterial growth inside macrophages and mice, using the radiometric (BACTEC) method. Tuber Lung Dis (1994) 1.48
In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun (1991) 1.47
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrob Agents Chemother (1988) 1.46
In vitro response of murine alveolar and peritoneal macrophages to Mycobacterium intracellulare. Am Rev Respir Dis (1983) 1.44
DOTS and beyond: towards a holistic approach to the conquest of tuberculosis. Int J Tuberc Lung Dis (1998) 1.43
In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli. Antimicrob Agents Chemother (1995) 1.43
Clinical significance of Mycobacterium fortuitum infections in pulmonary disease. Am Rev Respir Dis (1973) 1.37
Antimycobacterial activities of riminophenazines. J Antimicrob Chemother (1999) 1.32
Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport (2001) 1.26
Antituberculosis activities of clofazimine and its new analogs B4154 and B4157. Antimicrob Agents Chemother (1996) 1.16
Mycobacterial dormancy. Tuber Lung Dis (1995) 1.13
Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices. J Biomed Mater Res (1997) 1.13
Isoniazid, rifampin, and hepatotoxicity. Am Rev Respir Dis (1986) 1.12
Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. Am J Respir Crit Care Med (1995) 1.11
Antituberculosis activity of clarithromycin. Antimicrob Agents Chemother (1995) 1.10
Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment. J Infect Dis (1991) 1.10
A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone. Bull World Health Organ (1969) 1.09
Dynamic aspects of the in vitro chemotherapeutic activity of ansamycin (rifabutine) on mycobacterium intracellulare. Am Rev Respir Dis (1985) 1.04
In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli. J Antimicrob Chemother (1995) 1.03
Polymerase chain reaction detection of Mycobacterium tuberculosis in formalin-fixed tissue. Am J Respir Crit Care Med (1996) 1.03
Effect of rifabutin on the phagocytosis and intracellular growth of Mycobacterium intracellulare in mouse resident and activated peritoneal and alveolar macrophages. Am Rev Respir Dis (1987) 1.02
Antimycobacterial activity of a new rifamycin derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (T9). Antimicrob Agents Chemother (1995) 1.00
Pathobiological significance of colony morphology in Mycobacterium avium complex. Microb Pathog (1996) 0.99
In vivo activity of paromomycin against susceptible and multidrug-resistant Mycobacterium tuberculosis and M. avium complex strains. Antimicrob Agents Chemother (1994) 0.98
Chemotherapeutic activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium tuberculosis in C57BL/6 mice. Tuber Lung Dis (1996) 0.97
Keratitis due to Mycobacterium chelonei. Tubercle (1978) 0.96
Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer. Tuber Lung Dis (1994) 0.95
Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide. J Antimicrob Chemother (1995) 0.94
Oligodendrocyte degeneration and recovery after focal cerebral ischemia. Neuroscience (2010) 0.94
A sputum swab culture method for tubercle bacilli using cetrimide compared with two other swab culture methods and the concentration culture method. Tubercle (1969) 0.94
Activity of some antileprosy compounds against Mycobacterium intracellulare in vitro. Am Rev Respir Dis (1977) 0.93
Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. J Antimicrob Chemother (1991) 0.92
Letter: Mycobacterial contamination through tap water. Am Rev Respir Dis (1976) 0.90
Susceptibility of Mycobacterium intracellulare to hydrogen peroxide. Am Rev Respir Dis (1984) 0.89
Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain. J Cereb Blood Flow Metab (1999) 0.89
In vitro anti-mycobacterial activity of some new amino-glycoside antibiotics. Tubercle (1977) 0.89
Human immunodeficiency virus and Mycobacterium avium complex coinfection of monocytoid cells results in reciprocal enhancement of multiplication. J Infect Dis (1995) 0.85
In-vitro and intracellular antimycobacterial activity of trifluoperazine. J Antimicrob Chemother (1996) 0.84
Antimycobacterial activity of some potential chemotherapeutic compounds. Tubercle (1978) 0.84
Activity of aminosidine (paromomycin) for Mycobacterium tuberculosis and Mycobacterium avium. J Antimicrob Chemother (1994) 0.83
Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages. Tubercle (1990) 0.83
Mycobacterium abscessus infection in a puncture wound. Am Rev Respir Dis (1972) 0.83
Comparison of virulence of Mycobacterium avium complex (MAC) strains isolated from AIDS and non-AIDS patients. Microb Pathog (1994) 0.83
Inhibition of Mycobacterium intracellulare by some vitamin K and coenzyme Q analogues. Am Rev Respir Dis (1978) 0.83
Dynamic aspects of the activity of clofazimine against Mycobacterium intracellulare. Tubercle (1981) 0.82
In vitro and in vivo synergistic effect of isoniazid with streptomycin and clofazimine against Mycobacterium avium complex (MAC). Tuber Lung Dis (1994) 0.82
Heat shock treatment of macrophages causes increased release of superoxide anion. Infect Immun (1992) 0.81
Bioavailability and chemotherapeutic activity of clofazimine against Mycobacterium avium complex infections in beige mice following a single implant of a biodegradable polymer. J Antimicrob Chemother (1994) 0.81
Modulation of basal and postischemic leukocyte-endothelial adherence by nitric oxide. Stroke (1998) 0.80
Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia. Stroke (2000) 0.80
Hypoglycemia selectively abolishes hypoxic reactivity of pial arterioles in piglets: role of adenosine. Am J Physiol (1995) 0.79
Adenosine transport inhibition ameliorates postischemic hypoperfusion in pigs. Brain Res (1996) 0.79
Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin. Antimicrob Agents Chemother (1996) 0.78
Adenosine and cerebrovascular hyperemia during insulin-induced hypoglycemia in newborn piglet. Am J Physiol (1993) 0.77
Carryover of clofazimine into culture media. Antimicrob Agents Chemother (1995) 0.77
CD18-dependent leukocyte adherence and vascular injury in pig cerebral circulation after ischemia. Am J Physiol (1997) 0.77
Comparison of several culture media used for studies on mycobacteriophages. J Med Microbiol (1978) 0.77
Measurement of thorium isotopes and 228Ra in soft tissues and bones of a deceased Thorotrast patient. Health Phys (1992) 0.76
Differences in infectivity of isogenic variants of Mycobacterium avium by oral route. Tuber Lung Dis (1994) 0.76
Experimental infections with Mycobacterium intracellulare. Rev Infect Dis (1982) 0.76
Phage typing of mycobacteria using paper discs. Am Rev Respir Dis (1978) 0.75
Treatment of presumed asystole during pre-hospital cardiac arrest: superiority of electrical countershock. Am J Emerg Med (1985) 0.75
Presumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings. Am Rev Respir Dis (1990) 0.75
Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase. Am Rev Respir Dis (1987) 0.75
A sputum swab culture method for tubercle bacilli using Cetrimide, compared with two other swab culture methods and the concentration culture method. Indian J Med Res (1969) 0.75
Direct test for determining sensitivity of M. tuberculosis to streptomycin. Indian J Med Res (1972) 0.75
Cost reduction efforts in a tuberculosis laboratory. Chest (1987) 0.75
Inactivation index of isoniazid. J Antimicrob Chemother (1977) 0.75
Thiacetazone sensitivity of Indian tubercle bacilli. Tubercle (1968) 0.75
Atrial fibrillation with high degree atrioventricular block masquerading as ventricular fibrillation masquerading as asystole during cardiac arrest. Crit Care Med (1987) 0.75
BCG vaccination and non-tuberculous Mycobacteria. Tubercle (1981) 0.75
A comparison of four different methods for testing the production of a niacin by mycobacteria. Am Rev Respir Dis (1971) 0.75
Effect of storage for three months at different temperatures on the sensitivity to streptomycin and isoniazid of cultures of tubercle bacilli. Indian J Med Res (1967) 0.75
Drug resistance and drug susceptibility tests. Am Rev Respir Dis (1980) 0.75
Direct drug susceptibility test for tubercle bacilli by the sputum swab culture method. Int J Tuberc Lung Dis (2000) 0.75
Effect of hypoglycemia on postischemic cortical blood flow, hypercapnic reactivity, and interstitial adenosine concentration. J Neurosurg (1994) 0.75
Drug resistance in tuberculosis: it's not always the patient's fault! Tuber Lung Dis (1993) 0.75
Correspondence: Early discharge of patients with active tuberculosis. Am Rev Respir Dis (1974) 0.75
Acid-fastness of Mycobacteri,m tuberculosis H37Rv following infection by mycobacteriophage DS6A. Tubercle (1976) 0.75
Drug susceptibility or drug sensitivity. Am Rev Respir Dis (1985) 0.75
Chemotherapy of tuberculosis under program conditions. With special relevance to India. Tuber Lung Dis (1994) 0.75
Antituberculosis activity of 6 cyclo-octylamino-5,8-quinolinequinone (CQQ). Tubercle (1981) 0.75
Influence of other antimicrobial agents on the microbiological assay of ethambutol. J Antimicrob Chemother (1977) 0.75
Mechanisms of isoniazid release from poly(d,l-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods. J Pharm Sci (1996) 0.75
Letter: Intermittent chemotherapy of tuberculosis. Am Rev Respir Dis (1975) 0.75
Identification of mycobacteria by smear examination of the culture. Tubercle (1981) 0.75
An improved method for in vitro cultivation of murine splenic macrophages. In Vitro Cell Dev Biol (1990) 0.75
Clarithromycin for non-mycobacterial diseases? Int J Tuberc Lung Dis (1998) 0.75
Microbiological assay of ethambutol. J Antimicrob Chemother (1977) 0.75
Susceptibility of Mycobacteria to p-nitrobenzoic acid in relation to their niacin production. Am Rev Respir Dis (1973) 0.75
Direct sensitivity test for isoniazid. Indian J Med Res (1969) 0.75